Novo Nordisk A S (NVO) Interest & Investment Income (2012 - 2016)

Novo Nordisk A S (NVO) has 5 years of Interest & Investment Income data on file, last reported at $15.0 million in Q2 2016.

• Quarterly Interest & Investment Income rose 144.12% year-over-year to $15.0 million in Q2 2016, while the trailing twelve-month figure through Jun 2016 was $22.0 million (up 115.6% YoY) and the FY2019 annual result came in at $125.6 billion, up 13.4% from the prior year.
• Interest & Investment Income climbed to $15.0 million in Q2 2016, from $3.0 million in the prior quarter.
• In the past five years, Interest & Investment Income ranged from a high of $110.0 million in Q4 2013 to a low of -$208.0 million in Q4 2014.
• A 5-year average of $21.4 million and a median of $20.5 million in 2012 frame the typical range for Interest & Investment Income.
• Annual changes were most pronounced in 2013 — Interest & Investment Income surged 3566.67% — and 2014, when it tumbled 289.09%.
• Tracing NVO's Interest & Investment Income over 5 years: stood at $3.0 million in 2012, then surged by 3566.67% to $110.0 million in 2013, then plunged by 289.09% to -$208.0 million in 2014, then surged by 101.44% to $3.0 million in 2015, then soared by 400.0% to $15.0 million in 2016.
• The last three Interest & Investment Income figures came in at $15.0 million (Q2 2016), $3.0 million (Q1 2016), and $3.0 million (Q4 2015), per Business Quant data.